Lepu Medical Technology Beijing Co Ltd
SZSE:300003
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.06
17.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Lepu Medical Technology Beijing Co Ltd
Income from Continuing Operations
Lepu Medical Technology Beijing Co Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Income from Continuing Operations
¥672.5m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
5%
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Income from Continuing Operations
¥522.1m
|
CAGR 3-Years
71%
|
CAGR 5-Years
99%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Income from Continuing Operations
¥1.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
19%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Income from Continuing Operations
¥12.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Income from Continuing Operations
¥701.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Income from Continuing Operations
¥2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lepu Medical Technology Beijing Co Ltd
Glance View
Lepu Medical Technology (Beijing) Co. Ltd. engages in the research, development, production, and sale of medical equipment and accessories. The company is headquartered in Beijing, Beijing and currently employs 10,941 full-time employees. The company went IPO on 2009-10-30. The Company’s main products include stent systems, occluders, bulk drugs, clopidogrel sulfate, atorvastatin calcium tablets, pacemakers, in vitro diagnostic reagents and equipment and surgical instrument, among others. The firm distributes its products in domestic market and to overseas markets.
See Also
What is Lepu Medical Technology Beijing Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
672.5m
CNY
Based on the financial report for Sep 30, 2024, Lepu Medical Technology Beijing Co Ltd's Income from Continuing Operations amounts to 672.5m CNY.
What is Lepu Medical Technology Beijing Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
5%
Over the last year, the Income from Continuing Operations growth was -63%. The average annual Income from Continuing Operations growth rates for Lepu Medical Technology Beijing Co Ltd have been -29% over the past three years , -17% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
